Standard

To the question of co-occurrence of bipolar affective disorder and anxiety. / Petrova, N.

в: Psychiatry, Psychotherapy and Clinical Psychology, Том 7, № 2, 01.01.2016, стр. 258-265.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Petrova, N 2016, 'To the question of co-occurrence of bipolar affective disorder and anxiety', Psychiatry, Psychotherapy and Clinical Psychology, Том. 7, № 2, стр. 258-265.

APA

Petrova, N. (2016). To the question of co-occurrence of bipolar affective disorder and anxiety. Psychiatry, Psychotherapy and Clinical Psychology, 7(2), 258-265.

Vancouver

Petrova N. To the question of co-occurrence of bipolar affective disorder and anxiety. Psychiatry, Psychotherapy and Clinical Psychology. 2016 Янв. 1;7(2):258-265.

Author

Petrova, N. / To the question of co-occurrence of bipolar affective disorder and anxiety. в: Psychiatry, Psychotherapy and Clinical Psychology. 2016 ; Том 7, № 2. стр. 258-265.

BibTeX

@article{fb5349fe7b9f441b974c615c8cbefc14,
title = "To the question of co-occurrence of bipolar affective disorder and anxiety",
abstract = "Review of the literature showed that anxiety commonly co-occurs with bipolar disorders (BDs), but the significance of such {"}co-morbidity{"} remains not clarified and its optimal treatment can not be adequately defined. Nearly half of BD patients meet diagnostic criteria for an anxiety disorder at some time. Such co-morbidity is associated with poor treatment reactions, substance abuse, invalidism. Prevalence of this co-morbidity appears to be greater among women than men, but similar in BD types I and II. Anxiety may be more likely in depressive phases of BD, but relationships of anxiety phenomena to particular phases of BD and their temporal distributions require clarification. Benzodiazepines are sometimes given empirically; antidepressants are employed cautiously to limit risks of mood switching and emotional destabilization; lamotrigine, valproate, and secondgeneration antipsychotics may be useful and relatively safe.",
keywords = "Anxiety, Bipolar disorders, Co-morbidity",
author = "N. Petrova",
year = "2016",
month = jan,
day = "1",
language = "English",
volume = "7",
pages = "258--265",
journal = "Psychiatry, Psychotherapy and Clinical Psychology",
issn = "2220-1122",
publisher = "UE Professional Editions",
number = "2",

}

RIS

TY - JOUR

T1 - To the question of co-occurrence of bipolar affective disorder and anxiety

AU - Petrova, N.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Review of the literature showed that anxiety commonly co-occurs with bipolar disorders (BDs), but the significance of such "co-morbidity" remains not clarified and its optimal treatment can not be adequately defined. Nearly half of BD patients meet diagnostic criteria for an anxiety disorder at some time. Such co-morbidity is associated with poor treatment reactions, substance abuse, invalidism. Prevalence of this co-morbidity appears to be greater among women than men, but similar in BD types I and II. Anxiety may be more likely in depressive phases of BD, but relationships of anxiety phenomena to particular phases of BD and their temporal distributions require clarification. Benzodiazepines are sometimes given empirically; antidepressants are employed cautiously to limit risks of mood switching and emotional destabilization; lamotrigine, valproate, and secondgeneration antipsychotics may be useful and relatively safe.

AB - Review of the literature showed that anxiety commonly co-occurs with bipolar disorders (BDs), but the significance of such "co-morbidity" remains not clarified and its optimal treatment can not be adequately defined. Nearly half of BD patients meet diagnostic criteria for an anxiety disorder at some time. Such co-morbidity is associated with poor treatment reactions, substance abuse, invalidism. Prevalence of this co-morbidity appears to be greater among women than men, but similar in BD types I and II. Anxiety may be more likely in depressive phases of BD, but relationships of anxiety phenomena to particular phases of BD and their temporal distributions require clarification. Benzodiazepines are sometimes given empirically; antidepressants are employed cautiously to limit risks of mood switching and emotional destabilization; lamotrigine, valproate, and secondgeneration antipsychotics may be useful and relatively safe.

KW - Anxiety

KW - Bipolar disorders

KW - Co-morbidity

UR - http://www.scopus.com/inward/record.url?scp=85010402377&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85010402377

VL - 7

SP - 258

EP - 265

JO - Psychiatry, Psychotherapy and Clinical Psychology

JF - Psychiatry, Psychotherapy and Clinical Psychology

SN - 2220-1122

IS - 2

ER -

ID: 48634665